Special situations and coverage exceptions Certain situations create unique coverage considerations that do not fit neatly into standard prior authorization pathways
Data were collected in Qualtrics with safeguards against bots (reCAPTCHA, attention checks, honeypot items)
Glucagon-like peptide-1 receptor agonists, commonly referred to as GLP-1s, are becoming increasingly widespread, with the most notable examples including Ozempic, Wegovy, and Saxenda
Given the role of low grade inflammation in obesity, this approach may counter insulin resistance and metabolic dysfunction, and could be useful in T2D, autoimmune disorders, or neurodegenerative diseases [10, 12, 27,28,29]